Cas:57774-77-3 4-(tert-Butyl)benzothioamide manufacturer & supplier

We serve Chemical Name:4-(tert-Butyl)benzothioamide CAS:57774-77-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

4-(tert-Butyl)benzothioamide

Chemical Name:4-(tert-Butyl)benzothioamide
CAS.NO:57774-77-3
Synonyms:MFCD00052485;4-tert-butylbenzenecarbothioamide
Molecular Formula:C11H15NS
Molecular Weight:193.30800
HS Code:2930909090

Physical and Chemical Properties:
Melting point:145-148 °C
Boiling point:288.7ºC at 760 mmHg
Density:1.058g/cm3
Index of Refraction:1.58
PSA:58.11000
Exact Mass:193.09300
LogP:3.31860

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like MFCD00052485 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-tert-butylbenzenecarbothioamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-tert-butylbenzenecarbothioamide Use and application,4-tert-butylbenzenecarbothioamide technical grade,usp/ep/jp grade.


Related News: There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 4-(tert-Butyl)benzothioamide manufacturer There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect. 4-(tert-Butyl)benzothioamide supplier The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment. 4-(tert-Butyl)benzothioamide vendor The findings challenge past, smaller studies that found Black women face a greater genetic risk and the suggestion that race should be an independent factor when considering genetic testing,” said study first author Dr. Susan Domchek, executive director of the Basser Center for BRCA at the University of Pennsylvania’s Perelman School of Medicine.
“We shouldn’t make changes to testing guidelines based on race alone,” she said in a university news release. “Rather, our efforts should focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes. 4-(tert-Butyl)benzothioamide factory The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.